WASHINGTON, April 4, 2011 — The American Chemical Society (ACS) has named two new editors for its peer-reviewed Journal of Medicinal Chemistry — Gunda I. Georg, Ph.D., with the University of Minnesota’s College of Pharmacy, in Minneapolis, and Shaomeng Wang, Ph.D., with the University of Michigan in Ann Arbor.
They will share the position currently filled by Philip S. Portoghese, Ph.D., distinguished professor in the Department of Medicinal Chemistry in the University of Minnesota’s College of Pharmacy, who will retire from the journal at the end of the year after serving as its editor-in-chief for 40 years.
Georg, head of the department of medicinal chemistry in Minnesota’s College of Pharmacy, and Wang, professor of medicine, pharmacology and medicinal chemistry at Michigan, will assume joint leadership of the journal in January 2012.
“The two are an outstanding choice as the new editors of the journal,” says Portoghese, who plans to remain active in conducting research at Minnesota. “As both are well-recognized scientists in the field, they will undoubtedly be a magnet for exceptional authors.”
Georg holds the Robert Vince Endowed Chair and McKnight Presidential Chair and directs its Institute for Therapeutics Discovery & Development, which she established. She serves on the editorial advisory boards of ACS Medicinal Chemistry Letters and the Journal of Organic Chemistry, and previously served on the editorial advisory board of the Journal of Medicinal Chemistry. Born in Herborn, Germany, Georg received a B.S. in pharmacy in 1975, a Ph.D. in medicinal chemistry in 1980, and completed a postdoctoral fellowship in 1981, all at Philipps University of Marburg, in Germany. She then completed another post doctorate assignment at the University of Ottawa.
Wang is the Warner-Lambert/Parke-Davis Professor in Medicine, co-director of its Molecular Therapeutics Program, and director of its Cancer Drug Discovery Program. Currently, he is a senior editor of the Journal of Medicinal Chemistry and serves on the editorial advisory board of ACS Medicinal Chemistry Letters.
Born in Henan province, in China, Wang received a B.S. in chemistry from Peking University in 1986 and a Ph.D. in chemistry from Case Western Reserve University in 1992. After completing postdoctoral training in drug design at the National Cancer Institute in 1996, Wang served as assistant and associate professor at Georgetown University until 2001. He then joined the faculty at the University of Michigan Medical School as a tenured associate professor in 2001 and was promoted to professor in 2006.